Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the clinical response rate (complete response and
partial response) in patients with metastatic, locally advanced, or locally recurrent
vascular soft tissue sarcoma treated with sunitinib.